{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T16:21:48Z","timestamp":1761841308951},"reference-count":149,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,4,1]],"date-time":"2000-04-01T00:00:00Z","timestamp":954547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1053\/beog.1999.0075","type":"journal-article","created":{"date-parts":[[2002,7,28]],"date-time":"2002-07-28T21:49:59Z","timestamp":1027892999000},"page":"291-313","source":"Crossref","is-referenced-by-count":24,"title":["Drug therapy for urinary incontinence"],"prefix":"10.1053","volume":"14","author":[{"given":"K-E.","family":"Andersson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beog.1999.0075_RF1","series-title":"Incontinence, 1st International Consultation on Incontinence","first-page":"197","article-title":"Epidemiology and natural history of urinary incontinence","author":"Hunskaar","year":"1999"},{"key":"10.1053\/beog.1999.0075_RF2","series-title":"Incontinence, 1st International Consultation on Incontinence","first-page":"869","article-title":"Socioeconomic consideration","author":"Versi","year":"1999"},{"key":"10.1053\/beog.1999.0075_RF3","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1007\/PL00014139","article-title":"Medical treatment and medical side effects in urinary incontinence in the elderly","volume":"16","author":"Th\u00fcroff","year":"1998","journal-title":"World Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF4","series-title":"Incontinence, 1st International Consultation on Incontinence","first-page":"447","article-title":"Pharmacological treatment of urinary incontinence","author":"Andersson","year":"1999"},{"key":"10.1053\/beog.1999.0075_RF5","series-title":"Incontinence, 1st International Consultation on Incontinence","first-page":"105","article-title":"Basic neurophysiology and neuropharmacology","author":"de Groat","year":"1999"},{"key":"10.1053\/beog.1999.0075_RF6","first-page":"253","article-title":"Pharmacology of lower urinary tract smooth muscles and penile erectile tissues","volume":"45","author":"Andersson","year":"1993","journal-title":"Pharmacological Reviews"},{"key":"10.1053\/beog.1999.0075_RF7","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0090-4295(97)00591-8","article-title":"A myogenic basis for the overactive bladder","volume":"50","author":"Brading","year":"1997","journal-title":"Urology"},{"key":"10.1053\/beog.1999.0075_RF8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0090-4295(97)00587-6","article-title":"A neurological basis for the overactive bladder","volume":"50","author":"de Groat","year":"1997","journal-title":"Urology"},{"key":"10.1053\/beog.1999.0075_RF9","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0090-4295(97)00595-5","article-title":"The overactive bladder: pharmacological basis of drug treatments","volume":"50","author":"Andersson","year":"1997","journal-title":"Urology"},{"key":"10.1053\/beog.1999.0075_RF10","series-title":"Incontinence, 1st International Consultation on Incontinence","first-page":"227","article-title":"Pathophysiology","author":"De Lancey","year":"1999"},{"key":"10.1053\/beog.1999.0075_RF11","first-page":"531","article-title":"Muscarinic receptor subtypes and smooth muscle function","volume":"48","author":"Eglen","year":"1996","journal-title":"Pharmacological Reviews"},{"key":"10.1053\/beog.1999.0075_RF12","first-page":"279","article-title":"International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors","volume":"50","author":"Caulfield","year":"1998","journal-title":"Pharmacological Reviews"},{"key":"10.1053\/beog.1999.0075_RF13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1007\/PL00005114","article-title":"A re-appraisal of the nature of the atropine-resistant contraction to electrical field stimulation in the human isolated detrusor muscle","volume":"356","author":"Tagliani","year":"1997","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF14","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000052266","article-title":"The importance of the cholinergic system in neurourology","volume":"34","author":"Andersson","year":"1998","journal-title":"European Urology"},{"key":"10.1053\/beog.1999.0075_RF15","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0024-3205(98)00581-5","article-title":"Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder","volume":"64","author":"Hegde","year":"1999","journal-title":"Life Sciences"},{"key":"10.1053\/beog.1999.0075_RF15A","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S0022-5347(17)56251-5","article-title":"An objective comparison of the effects of parenterally administered drug in patients suffering from detrusor instability","volume":"122","author":"Cardozo","year":"1979","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0022-5347(17)55398-7","article-title":"Cystometric response to propantheline in detrusor hyperreflexia: therapeutic implications","volume":"124","author":"Blaivas","year":"1980","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365598109179583","article-title":"Influence of atropine and isoprenaline on detrusor hyperactivity in children with neurogenic bladder","volume":"15","author":"Naglo","year":"1981","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1053\/beog.1999.0075_RF18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0140-6736(77)91370-8","article-title":"A second look at emepronium bromide in urinary incontinence","volume":"i","author":"Ritch","year":"1977","journal-title":"Lancet"},{"key":"10.1053\/beog.1999.0075_RF19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1464-410X.1982.tb06968.x","article-title":"Urinary incontinence in old age. A controlled trial of emepronium bromide","volume":"54","author":"Walther","year":"1982","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1159\/000281002","article-title":"Effect of emepronium bromide (Cetiprin) on symptoms and urinary bladder function after transurethral resection of the prostate. A double-blind randomized trial","volume":"39","author":"Bonnesen","year":"1984","journal-title":"Urologia Internationalis"},{"key":"10.1053\/beog.1999.0075_RF21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/nau.1930050202","article-title":"Effectiveness of propantheline bromide in the treatment of geriatric patients with detrusor instability","volume":"5","author":"Zorzitto","year":"1986","journal-title":"Neurology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00003495-198835040-00006","article-title":"Current concepts in the treatment of disorders of micturition","volume":"35","author":"Andersson","year":"1988","journal-title":"Drugs"},{"key":"10.1053\/beog.1999.0075_RF23","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0094-0143(21)00530-9","article-title":"Pharmacology of incontinence","volume":"22","author":"Wein","year":"1995","journal-title":"Urological Clinics of North America"},{"key":"10.1053\/beog.1999.0075_RF24","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1464-410X.1974.tb03742.x","article-title":"The effect of Ubretid on bladder function after recent complete spinal cord injury","volume":"46","author":"Smith","year":"1974","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0163-7258(97)00085-5","article-title":"Non-neuronal acetylcholine, a locally acting molecule, widely expressed in biological systems: expression and function in humans","volume":"77","author":"Wessler","year":"1998","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1053\/beog.1999.0075_RF26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1464-410X.1986.tb09010.x","article-title":"Dose titration in clinical trials: an example using emepronium carrageenate in detrusor instability","volume":"58","author":"Massey","year":"1986","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0014-2999(97)89661-6","article-title":"Tolterodine\u2014a new bladder selective antimuscarinic agent","volume":"327","author":"Nilvebrant","year":"1997","journal-title":"European Journal of Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1600-0773.1997.tb02064.x","article-title":"Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine","volume":"81","author":"Nilvebrant","year":"1997","journal-title":"Pharmacology and Toxicology"},{"key":"10.1053\/beog.1999.0075_RF29","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0024-3205(97)00057-X","article-title":"Tolterodine\u2014a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data","volume":"60","author":"Nilvebrant","year":"1997","journal-title":"Life Sciences"},{"key":"10.1053\/beog.1999.0075_RF30","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/nau.1930140606","article-title":"Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity","volume":"14","author":"Stahl","year":"1995","journal-title":"Neurourology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0009-9236(98)90104-7","article-title":"Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamics of tolterodine","volume":"63","author":"Brynne","year":"1998","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"10.1053\/beog.1999.0075_RF32","first-page":"289","article-title":"Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes","volume":"26","author":"Postlind","year":"1998","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1053\/beog.1999.0075_RF33","first-page":"287","article-title":"Pharmacokinetics and pharmacodynamics of tolterodine in man: a new drug for the treatment of urinary bladder overactivity","volume":"35","author":"Brynne","year":"1997","journal-title":"International Journal of Clinical Pharmacology and Therapeutics"},{"key":"10.1053\/beog.1999.0075_RF34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003495-199855060-00008","article-title":"Tolterodine","volume":"55","author":"Hills","year":"1998","journal-title":"Drugs"},{"key":"10.1053\/beog.1999.0075_RF35","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/(SICI)1520-6777(1998)17:5<499::AID-NAU6>3.0.CO;2-8","article-title":"Dose-ranging study of tolterodine in patients with detrusor hyperreflexia","volume":"17","author":"van Kerrebroeck","year":"1998","journal-title":"Neurourology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF36","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0090-4295(98)00629-3","article-title":"Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data","volume":"53","author":"Larsson","year":"1999","journal-title":"Urology"},{"key":"10.1053\/beog.1999.0075_RF37","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0022-5347(05)68951-3","article-title":"Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity","volume":"161","author":"Millard","year":"1999","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF38","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1046\/j.1464-410x.1998.00717.x","article-title":"Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder","volume":"81","author":"Abrams","year":"1998","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0022-5347(17)36029-9","article-title":"Urodynamic effects of intravesical instillation of atropine and phentolamine in patients with detrusor hyperactivity","volume":"149","author":"Ekstr\u00f6m","year":"1992","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF40","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sc.1995.9","article-title":"Intravesical atropine and suppression of detrusor hypercontractility in the neuropathic bladder. A preliminary study","volume":"33","author":"Glickman","year":"1995","journal-title":"Paraplegia"},{"key":"10.1053\/beog.1999.0075_RF41","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0022-5347(01)65411-9","article-title":"The use of scopolamine in the treatment of detrusor instability","volume":"156","author":"Muskat","year":"1996","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF42","doi-asserted-by":"crossref","first-page":"473","DOI":"10.5694\/j.1326-5377.1996.tb138610.x","article-title":"Urinary urge incontinence: randomised crossover trials of penthienate versus placebo and propantheline","volume":"165","author":"Coombes","year":"1996","journal-title":"Medical Journal of Australia"},{"key":"10.1053\/beog.1999.0075_RF43","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000282207","article-title":"Effect of trospium chloride on urodynamic parameters in patients with detrusor hyperreflexia due to spinal cord injuries: a multicentre placebo controlled double-blind trial","volume":"47","author":"St\u00f6hrer","year":"1991","journal-title":"Urologia Internationalis"},{"key":"10.1053\/beog.1999.0075_RF44","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1464-410X.1995.tb07264.x","article-title":"Trospium chloride versus oxybutynin: a randomized, double-blind, multicentre trial in the treatment of detrusor hyper-reflexia","volume":"75","author":"Madersbacher","year":"1995","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF45","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0140-6736(91)90481-4","article-title":"Torsades de pointes complicating treatment with terodiline","volume":"338","author":"Connolly","year":"1981","journal-title":"Lancet"},{"key":"10.1053\/beog.1999.0075_RF46","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/BF00265918","article-title":"Terodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval","volume":"42","author":"Stewart","year":"1992","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF47","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF00558247","article-title":"The pharmacokinetics of oxybutynin in man","volume":"35","author":"Douchamps","year":"1988","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF48","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3109\/00498259209053145","article-title":"Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers","volume":"22","author":"Hughes","year":"1992","journal-title":"Xenobiotica"},{"key":"10.1053\/beog.1999.0075_RF49","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-5347(01)65148-6","article-title":"Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland","volume":"157","author":"Waldeck","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF50","first-page":"1012","article-title":"Comparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and their enantiomers with those of racemic terodiline","volume":"48","author":"Smith","year":"1998","journal-title":"Drug Research"},{"key":"10.1053\/beog.1999.0075_RF51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0014-2999(86)90697-7","article-title":"Dicyclomine, benzhexol and oxybutynin distinguish between subclasses of muscarinic binding sites","volume":"23","author":"Nilvebrant","year":"1986","journal-title":"European Journal of Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF52","first-page":"562","article-title":"Enantiomers of oxybutynin: in vitro pharmacological characterization at M1, M2 and M3 muscarinic receptors and in vivo effects on urinary bladder contraction, mydriasis and salivary secretion in guinea pigs","volume":"256","author":"Norhona-Blob","year":"1991","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1053\/beog.1999.0075_RF53","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs and Aging"},{"key":"10.1053\/beog.1999.0075_RF54","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/bmj.304.6833.1053","article-title":"Low dose oxybutynin for the unstable bladder","volume":"304","author":"Malone-Lee","year":"1992","journal-title":"British Medical Journal"},{"key":"10.1053\/beog.1999.0075_RF55","first-page":"5","article-title":"Qualit\u00e9 de vie des femmes souffrant d'imp\u00e9riosit\u00e9 mictionelle avec ou sans fuites: \u00e9tude prospective apr\u00e9s traitement par oxybutinine (1701 cas)","volume":"27","author":"Amarenco","year":"1998","journal-title":"Presse Medicale"},{"key":"10.1053\/beog.1999.0075_RF56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1464-410X.1988.tb04356.x","article-title":"Oxybutynin: is it safe?","volume":"62","author":"Baigrie","year":"1988","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF57","first-page":"389","article-title":"Effets ind\u00e9sirables du chlorure d'oxybutynine (Ditropan\u00ae)","volume":"47","author":"Jonville","year":"1992","journal-title":"Therapie"},{"key":"10.1053\/beog.1999.0075_RF58","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0022-5347(17)35130-3","article-title":"The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia","volume":"151","author":"Kasabian","year":"1994","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF59","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S0022-5347(01)65238-8","article-title":"Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population","volume":"157","author":"Palmer","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF60","first-page":"346","article-title":"The pharmacokinetic properties of rectal oxybutynin\u2014a possible alternative to intravesical administration","volume":"16","author":"Collas","year":"1997","journal-title":"Neurourology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF61","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/(SICI)1520-6777(1997)16:6<533::AID-NAU3>3.0.CO;2-F","article-title":"Comparison of a 10-mg controlled release oxybutynin tablet with a 5-mg oxybutynin tablet in urge incontinent patients","volume":"16","author":"Nilsson","year":"1997","journal-title":"Neurourology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF62","first-page":"36","article-title":"Open-label safety and dose conversion\/determination of once-daily OROS\u00aeoxybutynin for urge urinary incontinence","volume":"159","author":"Susset","year":"1998","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF63","first-page":"815","article-title":"Inhibitory effects of propiverine hydrochloride on the agonist-induced or spontaneous contractions of various isolated muscle preparations","volume":"42","author":"Haruno","year":"1992","journal-title":"Arzneimittel-Forschung\/Drug Research"},{"key":"10.1053\/beog.1999.0075_RF64","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/BF00167244","article-title":"Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle","volume":"348","author":"Tokuno","year":"1993","journal-title":"Naunyn-Schmiedeberg's Archives of Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF65","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/BF03188807","article-title":"Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine","volume":"18","author":"Muller","year":"1993","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"key":"10.1053\/beog.1999.0075_RF66","unstructured":"Richter, R, Madersbacher, H, Stohrer, M, Double-blind, placebo-controlled clinical study of propiverine in patients suffering from detrusor hyperreflexia, 1997"},{"key":"10.1053\/beog.1999.0075_RF67","first-page":"259","article-title":"Comparative investigations to the action of Mictonorm (propiverin hydrochloride) and Spasuret (flavoxat hydrochloride) on detrusor vesicae","volume":"82","author":"Wehnert","year":"1989","journal-title":"Zeitschrift f\u00fcr Urologie und Nephrologie"},{"key":"10.1053\/beog.1999.0075_RF68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2008-1060401","article-title":"Therapie der blaseninstabilit\u00e4t und Urge-Inkontinenz mit Propiverin hydrochlorid (Mictonorm\u00ae) und Oxybutynin chlorid (Dridase\u00ae\u2014eine randomisierte Cross-over-Vergleichsstudie","volume":"23","author":"Wehnert","year":"1992","journal-title":"Aktuelle Urologie"},{"key":"10.1053\/beog.1999.0075_RF69","unstructured":"Madersbacher, H, Halaska, M, Voigt, R, A urodynamic controlled multicenter study in patients with urge incontinence: tolerability and efficacy of propiverine in comparison to oxybutynin, 1997"},{"key":"10.1053\/beog.1999.0075_RF70","first-page":"91","article-title":"A review of flavoxate: pharmacology and mechanism of action","volume":"30","author":"Guarneri","year":"1994","journal-title":"Drugs Today"},{"key":"10.1053\/beog.1999.0075_RF71","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(96)00355-1","article-title":"Brain pertussis toxin-sensitive G proteins are involved in the flavoxate hydrochloride-induced suppression of the micturition reflex in rats","volume":"727","author":"Oka","year":"1996","journal-title":"Brain Research"},{"key":"10.1053\/beog.1999.0075_RF72","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/030006058801600501","article-title":"A review of flavoxate hydrochloride in the treatment of urge incontinence","volume":"16","author":"Ruffmann","year":"1988","journal-title":"Journal of International Medical Research"},{"key":"10.1053\/beog.1999.0075_RF73","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0022-5347(17)56078-4","article-title":"The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly","volume":"123","author":"Briggs","year":"1980","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF74","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1464-410X.1990.tb14994.x","article-title":"Double-blind, placebo-controlled, cross-over study of flavoxate in the treatment of idiopathic detrusor instability","volume":"66","author":"Chapple","year":"1990","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF75","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000282787","article-title":"Flavoxate treatment of micturition disorders accompanying benign prostatic hypertrophy: a double-blind placebo-controlled multicenter investigation","volume":"55","author":"Dahm","year":"1995","journal-title":"Urologia Internationalis"},{"key":"10.1053\/beog.1999.0075_RF76","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/ageing\/15.5.299","article-title":"Double-blind study of imipramine and placebo for incontinence due to bladder instability","volume":"15","author":"Castleden","year":"1986","journal-title":"Age and Ageing"},{"key":"10.1053\/beog.1999.0075_RF77","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1464-410X.1984.tb05355.x","article-title":"Fluphenazine\/nortriptyline in the irritative bladder syndrome: a double-blind placebo-controlled study","volume":"56","author":"Martin","year":"1984","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF78","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0022-5347(17)38976-0","article-title":"Doxepin in the treatment of female detrusor overactivity: a randomized double-blind crossover study","volume":"142","author":"Lose","year":"1989","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF79","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003495-199244010-00004","article-title":"Drug therapy for nocturnal enuresis","volume":"44","author":"Miller","year":"1992","journal-title":"Drugs"},{"key":"10.1053\/beog.1999.0075_RF80","series-title":"The Pharmacological Basis of Therapeutics","first-page":"387","article-title":"Drugs in the treatment of psychiatric disorders","author":"Baldessarini","year":"1985"},{"key":"10.1053\/beog.1999.0075_RF81","first-page":"278","article-title":"The effect of acute and chronic administration of imipramine on spinal and supraspinal micturition reflexes in rats","volume":"248","author":"Maggi","year":"1989","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1053\/beog.1999.0075_RF82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1472-8206.1996.tb00144.x","article-title":"Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications","volume":"10","author":"Pairet","year":"1996","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF83","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/bmj.280.6210.281","article-title":"Evaluation of flurbiprofen in detrusor instability","volume":"280","author":"Cardozo","year":"1980","journal-title":"British Medical Journal"},{"key":"10.1053\/beog.1999.0075_RF84","first-page":"11","article-title":"Report of a double-blind crossover study of flurbiprofen and placebo in detrusor instability","volume":"11","author":"Palmer","year":"1993","journal-title":"Journal of International Medical Research"},{"key":"10.1053\/beog.1999.0075_RF85","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0022-5347(17)55955-8","article-title":"A comparison between bromocriptine and indomethacin in the treatment of detrusor instability","volume":"123","author":"Cardozo","year":"1980","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF86","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1542\/peds.92.3.420","article-title":"Desmopressin acetate and nocturnal enuresis: how much do we know?","volume":"92","author":"Moffat","year":"1993","journal-title":"Pediatrics"},{"key":"10.1053\/beog.1999.0075_RF87","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0022-5347(01)65190-5","article-title":"Oral desmopressin as a new treatment modality for primary nocturnal enuresis in adolescents and adults: a double-blind, randomized, multicenter study","volume":"157","author":"Janknegt","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF88","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0022-5347(01)64383-0","article-title":"Oral desmopressin: a randomized double-blind placebo controlled study of effectiveness in children with primary nocturnal enuresis","volume":"158","author":"Skoog","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF89","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/00365598009179551","article-title":"Evaluation of a synthetic vasopressin analogue for treatment of nocturia in benign prostatic hypertrophy","volume":"14","author":"M\u00e5nsson","year":"1980","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1053\/beog.1999.0075_RF90","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1464-410X.1982.tb06969.x","article-title":"The use of desmopressin (DDAVP) in nocturnal frequency in the female","volume":"54","author":"Hilton","year":"1982","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF91","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1136\/jnnp.46.9.854","article-title":"The use of desmopressin (DDAVP) for nocturia in women with multiple sclerosis","volume":"46","author":"Hilton","year":"1983","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1053\/beog.1999.0075_RF92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3109\/00365599009180373","article-title":"Desmopressin: a new principle for symptomatic treatment of urgency and incontinence in patients with multiple sclerosis","volume":"24","author":"Kinn","year":"1990","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1053\/beog.1999.0075_RF93","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1464-410X.1994.tb07116.x","article-title":"Desmopressin in the treatment of nocturia and enuresis in patients with multiple sclerosis","volume":"74","author":"Eckford","year":"1994","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF94","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.1996.tb00035.x","article-title":"Nasal spray desmopressin treatment of bladder dysfunction in patients with multiple sclerosis","volume":"94","author":"Fredrikson","year":"1996","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1053\/beog.1999.0075_RF95","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/S0022-5347(01)68232-6","article-title":"Desmopressin for nocturnal incontinence in the spina bifida population","volume":"158","author":"Horowitz","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF96","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/BF02282887","article-title":"Hyponatremia in patients with nocturnal enuresis treated with DDAVP","volume":"155","author":"Robson","year":"1996","journal-title":"European Journal of Pediatrics"},{"key":"10.1053\/beog.1999.0075_RF97","first-page":"668","article-title":"Hyponatraemia and cerebral convulsion due to DDAVP administration in patients with enuresis nocturna or urine concentration testing","volume":"156","author":"Schwab","year":"1997","journal-title":"European Journal of Pediatrics"},{"key":"10.1053\/beog.1999.0075_RF98","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1600-0773.1992.tb00466.x","article-title":"Clinical pharmacology of potassium channel openers","volume":"70","author":"Andersson","year":"1992","journal-title":"Pharmacology and Toxicology"},{"key":"10.1053\/beog.1999.0075_RF99","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/(SICI)1097-0045(19970215)30:3<202::AID-PROS9>3.0.CO;2-N","article-title":"Prostatic \u03b11-adrenoceptors and uroselectivity","volume":"30","author":"Andersson","year":"1997","journal-title":"Prostate"},{"key":"10.1053\/beog.1999.0075_RF100","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/00365598109179608","article-title":"Uninhibited neurogenic bladder treated with prazosin","volume":"15","author":"Jensen","year":"1981","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1053\/beog.1999.0075_RF101","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/00365598909180840","article-title":"Prozosin treatment of neurological patients with detrusor hyperreflexia and bladder emptying disability","volume":"23","author":"Petersen","year":"1989","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1053\/beog.1999.0075_RF102","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1651-2227.1991.tb11956.x","article-title":"Influence of adrenergic agonists and antagonists on urethral pressure, bladder pressure and detrusor hyperactivity in children with myelodysplasia","volume":"80","author":"\u00c5mark","year":"1991","journal-title":"Acta Paediatrica Scandinavica"},{"key":"10.1053\/beog.1999.0075_RF103","first-page":"391","article-title":"Does sexual equality extend to urinary symptoms?","volume":"12","author":"Jollys","year":"1993","journal-title":"Neurourology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF104","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/0090-4295(93)90332-5","article-title":"Comparison of the AUA symptom index in unselected males and females between 55 and 79 years of age","volume":"42","author":"Lepor","year":"1993","journal-title":"Urology"},{"key":"10.1053\/beog.1999.0075_RF105","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1520-6777(1998)17:1<31::AID-NAU6>3.0.CO;2-E","article-title":"Prospective study comparing hyoscyamine, doxazosin, and combination therapy for the treatment of urgency and frequency in women","volume":"17","author":"Serels","year":"1998","journal-title":"Neurourology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF106","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1046\/j.1365-2125.1996.04222.x","article-title":"Clinical pharmacology of \u03b23-adrenoceptors","volume":"43","author":"Lipworth","year":"1996","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF107","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0165-6147(96)80011-3","article-title":"Function and regulation of the \u03b23-adrenoceptor","volume":"17","author":"Strosberg","year":"1997","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1053\/beog.1999.0075_RF108","first-page":"175","article-title":"Functional and molecular biological evidence of \u03b23-adrenoceptors in the human detrusor","volume":"157","author":"Igawa","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF109","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0702358","article-title":"Functional and molecular biological evidence for a possible beta3-adrenoceptor in the human detrusor muscle","volume":"126","author":"Igawa","year":"1999","journal-title":"British Journal of Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF110","first-page":"1367","article-title":"Evidence for \u03b23-adrenoceptor subtypes in relaxation of the human urinary bladder detrusor: analysis by molecular biological and pharmacological methods","volume":"288","author":"Takeda","year":"1999","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1053\/beog.1999.0075_RF111","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1471-0528.1984.tb04767.x","article-title":"Treatment of motor urge incontinence with clenbuterol and flavoxate hydrochloride","volume":"91","author":"Gr\u00fcneberger","year":"1984","journal-title":"British Journal of Obstetrics and Gynaecology"},{"key":"10.1053\/beog.1999.0075_RF112","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1365-2125.1980.tb00519.x","article-title":"The effect of \u03b2-adrenoceptor agonists on urinary incontinence in the elderly","volume":"10","author":"Castleden","year":"1980","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1053\/beog.1999.0075_RF113","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0022-5347(17)37048-9","article-title":"Effects of acute bolus and chronic continuous intrathecal baclofen on genitourinary dysfunction due to spinal cord pathology","volume":"148","author":"Steers","year":"1992","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF114","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/nau.1930120210","article-title":"Voiding dysfunction in patients with spastic paraplegia: urodynamic evaluation and response to continuous intrathecal baclofen","volume":"12","author":"Bushman","year":"1993","journal-title":"Neurourology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF115","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1464-410X.1979.tb03588.x","article-title":"A double-blind crossover trial of baclofen\u2014a new treatment for the unstable bladder syndrome","volume":"51","author":"Taylor","year":"1979","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF116","series-title":"Nervous Control of the Urogenital System","first-page":"383","article-title":"The dual, sensory and \u2018efferent\u2019 function of the capsaicin-sensitive primary sensory neurons in the urinary bladder and urethra","volume":"3","author":"Maggi","year":"1993"},{"key":"10.1053\/beog.1999.0075_RF117","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/0140-6736(92)91186-C","article-title":"Intravesical capsaicin for neurogenic bladder dysfunction","volume":"339","author":"Fowler","year":"1992","journal-title":"Lancet"},{"key":"10.1053\/beog.1999.0075_RF118","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/S0022-5347(01)66793-4","article-title":"Clinical and urodynamic effects of intravesical capsaicin treatment in patients with chronic traumatic spinal detrusor hypereflexia","volume":"154","author":"Geirsson","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF119","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1046\/j.1464-410X.1996.09844.x","article-title":"Urodynamic changes during therapeutic intravesical instillations of capsaicin","volume":"77","author":"Chandiramani","year":"1996","journal-title":"British Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF120","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0022-5347(01)65211-X","article-title":"Desensitization of bladder sensory fibers by intravesical capsaicin has long lasting clinical and urodynamic effects in patients with hyperactive or hypersensitive bladder dysfunction","volume":"157","author":"Cruz","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF121","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0022-5347(01)68162-X","article-title":"Intravesical capsaicin as a treatment for refractory detrusor hyperreflexia: a dual center study with long-term follow up","volume":"158","author":"De Ridder","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF122","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.sc.3100505","article-title":"The effects of capsaicin on the neurogenic hyperreflexic detrusor. A double blind placebo controlled study in patients with spinal cord disease. Preliminary results","volume":"36","author":"Wiart","year":"1998","journal-title":"Spinal Cord"},{"key":"10.1053\/beog.1999.0075_RF123","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000019531","article-title":"Treating the human bladder with capsaicin: is it safe?","volume":"33","author":"Dasgupta","year":"1998","journal-title":"European Urology"},{"key":"10.1053\/beog.1999.0075_RF124","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0022-5347(01)67121-0","article-title":"Urodynamic effects of intravesical resiniferatoxin and capsaicin in conscious rats with and without outflow obstruction","volume":"154","author":"Ishizuka","year":"1995","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF125","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0022-5347(01)68164-3","article-title":"Urodynamic effects of intravesical resiniferatoxin in humans: preliminary results in stable and unstable detrusor","volume":"158","author":"Lazzeri","year":"1997","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF126","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S0140-6736(05)63330-2","article-title":"Suppression of bladder hyperreflexia by intravesical resiniferatoxin","volume":"350","author":"Cruz","year":"1997","journal-title":"Lancet"},{"key":"10.1053\/beog.1999.0075_RF127","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0378-5122(93)90028-G","article-title":"Oestriol in the treatment of postmenopausal urgency: a multicentre study","volume":"18","author":"Cardozo","year":"1993","journal-title":"Maturitas"},{"key":"10.1053\/beog.1999.0075_RF128","first-page":"578","article-title":"Conservative therapy of female stress incontinence. Double-blind study with the alpha-sympathomimetic midodrin","volume":"102","author":"Gnad","year":"1984","journal-title":"Fortschritte der Medizin"},{"key":"10.1053\/beog.1999.0075_RF129","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000280997","article-title":"Clinical and urodynamic effects of norfenefrine in women with stress incontinence","volume":"39","author":"Lose","year":"1984","journal-title":"Urologia Internationalis"},{"key":"10.1053\/beog.1999.0075_RF130","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/0090-4295(75)90113-2","article-title":"Ephedrine in treatment of urinary incontinence","volume":"5","author":"Diokno","year":"1975","journal-title":"Urology"},{"key":"10.1053\/beog.1999.0075_RF131","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/00365597809179974","article-title":"The effects of long-term treatment with norephedrine on stress incontinence and urethral closure profile","volume":"12","author":"Ek","year":"1978","journal-title":"Scandinavian Journal of Urology and Nephrology"},{"key":"10.1053\/beog.1999.0075_RF132","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0090-4295(87)90314-1","article-title":"Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients","volume":"40","author":"Collste","year":"1987","journal-title":"Urology"},{"key":"10.1053\/beog.1999.0075_RF133","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0090-4295(88)90400-1","article-title":"Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women","volume":"32","author":"Kinn","year":"1988","journal-title":"Urology"},{"key":"10.1053\/beog.1999.0075_RF134","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000293211","article-title":"Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence","volume":"30","author":"Ahlstr\u00f6m","year":"1990","journal-title":"Gynecological and Obstetrical Investigation"},{"key":"10.1053\/beog.1999.0075_RF135","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S0022-5347(17)49941-1","article-title":"Conservative treatment of female stress incontinence with imipramine","volume":"132","author":"Gilja","year":"1984","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF136","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/BF00571623","article-title":"A double-blind clinical trial of a \u03b22-adrenergic agonist in stress incontinence","volume":"4","author":"Yasuda","year":"1993","journal-title":"International Urogynecology Journal"},{"key":"10.1053\/beog.1999.0075_RF137","first-page":"1014","article-title":"Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat","volume":"274","author":"Thor","year":"1995","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1053\/beog.1999.0075_RF138","unstructured":"Zinner, N, Sarshik, S, Yalcin, I, Efficacy and safety of duloxetine in stress urinary incontinent patients: double blind, placebo-controlled multiple dose study, 1998"},{"key":"10.1053\/beog.1999.0075_RF139","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0029-7844(96)00281-5","article-title":"Efficacy of estrogen supplementation in the treatment of urinary incontinence","volume":"88","author":"Fantl","year":"1996","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.1999.0075_RF140","first-page":"322","article-title":"The effect of oestradiol on objective urinary leakage in postmenopausal stress incontinence; a double blind placebo controlled trial","volume":"15","author":"Jackson","year":"1996","journal-title":"Neurourology and Urodynamics"},{"key":"10.1053\/beog.1999.0075_RF141","first-page":"12","article-title":"Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee","volume":"83","author":"Fantl","year":"1994","journal-title":"Obstetrics and Gynecology"},{"key":"10.1053\/beog.1999.0075_RF142","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0378-5122(94)90008-6","article-title":"Estrogen and urinary incontinence in women","volume":"20","author":"Sultana","year":"1990","journal-title":"Maturitas"},{"key":"10.1053\/beog.1999.0075_RF143","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000280978","article-title":"Urethral insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination","volume":"39","author":"Beisland","year":"1984","journal-title":"Urologia Internationalis"},{"key":"10.1053\/beog.1999.0075_RF144","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/BF00600027","article-title":"Oral and intravaginal estrogens alone and in combination with alpha adrenergic stimulation in genuine stress incontinence","volume":"12","author":"Hilton","year":"1990","journal-title":"International Urogynaecology Journal"},{"key":"10.1053\/beog.1999.0075_RF145","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0022-5347(17)47234-X","article-title":"Is bethanechol chlorode clinically effective in promoting bladder emptying: a literature review","volume":"134","author":"Finkbeiner","year":"1985","journal-title":"Journal of Urology"},{"key":"10.1053\/beog.1999.0075_RF146","series-title":"Urodynamics, Principles, Practice, and Application","first-page":"43","article-title":"Pharmacologic treatment of voiding dysfunction","author":"Wein","year":"1994"},{"key":"10.1053\/beog.1999.0075_RF147","first-page":"322","article-title":"The sympathetic innervation and adrenoreceptor function of the human lower urinary tract in the normal state and after parasympathetic denervation","volume":"14","author":"Sundin","year":"1977","journal-title":"Investigative Urology"},{"key":"10.1053\/beog.1999.0075_RF148","first-page":"39","article-title":"Effects of prazosin on isolated human urethra and in patients with lower motor neuron lesions","volume":"19","author":"Andersson","year":"1981","journal-title":"Investigative Urology"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693499900755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693499900755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T23:30:25Z","timestamp":1682292625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693499900755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":149,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["S1521693499900755"],"URL":"https:\/\/doi.org\/10.1053\/beog.1999.0075","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}